Genetic Tech Ltd.-SP ADRGENE
13F holders, Q1 2024 (March 31)6holders
$2.89avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding Genetic Tech Ltd.-SP ADR (GENE) in their 13F filings. The largest holders were Susquehanna International Group, LLP ($100K), Morgan Stanley ($51K) and BNP Paribas Financial Markets ($26K).
- Company
- Genetic Tech Ltd.-SP ADR
- CUSIP
- 37185R406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $126K |
| Exits | 2 | $312 |
Ownership 6 holders
| Susquehanna International Group, LLP | 0.00% | New | 34,596 | $100K |
| Morgan Stanley | 0.00% | Add +1.2% | 17,489 | $51K |
| BNP Paribas Financial Markets | 0.00% | New | 9,100 | $26K |
| Rhumbline Advisers | 0.00% | No change | 3,739 | $11K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $1K |
| UBS Group AG | 0.00% | Reduce -92.7% | 219 | $633 |
"% of holder's portfolio" is GENE's weight in each manager's 13F, not the share of Genetic Tech Ltd.-SP ADR the manager owns.